| Application no. and date | 16718802.8 (espacenet) (Federated) (European Patent Register), 20160412 | | Patent/reg. no. and date | DK/EP 3283527, 20210113 | | Publication date | 20180221 | | Priority no. and date | US 201562146766 P, 20150413, US 201562190945 P, 20150710 | | EP pub. no. and date |
EP 3283527 20180221 | | Effective date | | | Applicant/owner | Five Prime Therapeutics, Inc., 111 Oyster Point Boulevard
South San Francisco, CA 94080, US | | Applicant ref. no. | V157239DK | | Inventor | WONG, Brian, Two Corporate Drive
South San Francisco, California 94080, US,
MASTELLER, Emma, Two Corporate Drive
South San Francisco, California 94080, US,
BAKER, Kevin, Two Corporate Drive
South San Francisco, California 94080, US,
BELLOVIN, David, Two Corporate Drive
South San Francisco, California 94080, US,
BRENNAN, Thomas, Two Corporate Drive
South San Francisco, California 94080, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) | | Title | KOMBINATIONSTERAPI MOD CANCER | | Int. application no. | US2016027038 | | Int. publication no. | WO2016168149 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
